Studies Show Medical Marijuana Could Replace Adderall
In February 2015, it was reported that ADHD drug sales have been through the roof and will reach $1.75 billion by 2020. Back in 2012, Pediatrician Dr. Michael Anderson told New York Times, "We’ve decided as a society that it’s too expensive to modify the kid’s environment. So we have to modify the kid."
But as perceptions continue to transform, more medical studies are being conducted to determine the potential benefits of medicinal marijuana. Leafly last year reported the findings of cannabis researcher Dr. David Bearman, who found similarities in the effect that marijuana and prescriptions like Adderall and Ritalin have on dopamine levels.
"Cannabis appears to treat ADD and ADHD by increasing the availability of dopamine. This then has the same effect but is a different mechanism of action than stimulants like Ritalin and dexedrine amphetamine, which act by binding to the dopamine and interfering with the metabolic breakdown of dopamine."
Leafly continued to summarize Dr. Bearman's findings explaining that weed can correct dopamine levels and help to regulate the amount of information and the rate at which it is entering the brain and being processed.
"...the compounds found in cannabis, called cannabinoids, could potentially correct the dopamine deficiency observed in ADD/ADHD patients if dosed appropriately and administered safely. Even in its raw form, cannabis is able to provide the mental slowdown necessary for concentration in many patients."
Another study is showing that, when given the choice, ADD/ADHD patients prefer medical marijuana as it improves symptoms without side effects such as loss of appetite. As more legislation is passed to open the doors for more research, marijuana could be a future option for safer and more effective ADHD treatment.